Key facts
- 82% of adults with type 2 diabetes not on insulin improved blood glucose levels with continuous glucose monitoring.
- Continuous glucose monitoring (CGM) shows potential for diabetes management in primary care.
- The American Diabetes Association (ADA) announced winners of its 2026 Innovation Challenge.
- Awards were presented at the 2026 ADA Scientific Sessions.
- The 2026 ADA Scientific Sessions were held in New Orleans.
A recent study indicates that continuous glucose monitoring (CGM) significantly improves blood glucose levels for a large majority of adults with type 2 diabetes who are not on insulin. The findings show that 82% of these individuals experienced enhanced blood glucose control when utilizing CGM technology. This suggests that CGM could play a more prominent role in primary care settings for the ongoing management of type 2 diabetes.
In related news, the American Diabetes Association (ADA) has revealed the recipients of its 2026 Innovation Challenge awards. The awards ceremony took place on the main stage at the ADA's 2026 Scientific Sessions, which were held in New Orleans. The Innovation Challenge aims to foster advancements in diabetes research and care.